Novo Nordisk is a major pharmaceutical company that set out to challenge diabetes on the other side of the world. Using a “triple bottom line” of being socially and environmentally responsible, as well as financially responsible, it set out to ensure that diabetes sufferers received the treatment they need.


Similar resources